Navigation Links
Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
Date:3/5/2009

that penetrates into the oil glands and is applied to the skin one hour prior to treatment. As it penetrates, ALA binds to the oil glands and sensitizes the cells to light.

The 14 patients treated with ALA PDT received one to six treatments depending on the severity of their acne and continued to use topical medications during and after the study. The control group consisted of four patients who were either treated with conventional therapy (such as systemic or topical medications) or with laser energy but without ALA PDT.

Upon analyzing the data, Dr. Alexiades-Armenakas found that all (100 percent) of the 14 patients in the ALA PDT treatment group experienced complete clearance of their acne. She reported that an average of 2.9 ALA PDT treatments was administered to this patient group and improvement in the acne lesions was visible within one to two weeks after the first treatment. By comparison, none of the four patients in the control group who were treated with either laser energy alone or conventional therapy achieved complete clearance of their acne.

"The first-of-a-kind study found this particular form of photodynamic therapy used in conjunction with topical therapy to be the first such treatment to achieve complete clearance of acne up to 13 months post treatment and a 77 percent clearance rate per treatment. Four subsequent studies conducted by other investigators involving an additional 75 patients demonstrated similar results," said Dr. Alexiades-Armenakas. "Patients also experienced an added benefit of significant improvement in their acne scars, as the pulsed dye laser offers superior penetration to the deeper layers of the skin where scars form."

Side effects were limited to mild redness that lasted for 48 hours, and the treatment was found to be safe even for patients of color with no complications, such as hyperpigmentation.

In her practice, Dr. Alexiades-A
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
8. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
9. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
10. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
11. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ARK, Ill., Nov. 19 The ... as one of its Most Admired Corporate Dealmakers f...d Abbott as its Most Admired Dealmaker in pharma/b...uisitions and divestitures since January 2006. ,...usiness portfolio with a focus on high-growth, inn...
(Date:11/19/2009)...of International Internet Week of Action ,, SI...-- The U.S. Food and Drug Administration today com...rt, called the International Internet Week of Acti...ing medical products. ,, (Logo: http://www.new...ing the effort, the FDA,s Office of Criminal Inves...
(Date:11/19/2009)...ON, N.J., Nov. 19 Impliant, Inc., ...o traditional spinal fusion surgery, announced tod...anagement team as the Vice President of Clinical a...w.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ...regulatory experience in the spinal and medical de...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Mobile MedCheck Brings Back House Calls 54959 1Mobile MedCheck Brings Back House Calls 54959 2Mobile MedCheck Brings Back House Calls 54959 3Mobile MedCheck Brings Back House Calls 54959 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
...ree Oritavancin Studies Presented at ECCMID/ICC, M...ganta,Therapeutics today announced results from tw...cin to stop bacterial growth in vitro,when tested ...ne,study demonstrating the activity of oritavancin...ia. Oritavancin, a novel,lipoglycopeptide antibiot...
...istorical Analyses Help Plan for Future Pandemics ...tent riddles of the,deadly 1918 Spanish influenza ...rying severity. Why were some municipalities such ...s like Philadelphia,when both implemented similar ...according to two independent studies funded by the...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNew...90s to eliminate onchocerciasis (river blindness) ...alence of the disease in recent years, as evidence...equiring mass drug administration in six endemic c... annual meeting of the American Society of Tropica...
(Date:11/21/2009)... HAPPYneuron,s most popul...e on the iPhone and iPod Touch. , ...09 -- HAPPYneuron,s most popular and addictive gam...iPod Touch. Split Words is designed to help banish...he SplitWords iPhone brain game challenges the b...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fir...today that a Special Meeting of Shareholders will ...of the Meeting is to consider approval of two spec...o approve and authorize the sale of all or substan... on the terms provided for in the asset purchase a...
(Date:11/20/2009)..., , MADISON, N.J., Nov. 20 /PRNewswire-F...nfluenza virus may have peaked in late October, bu...al source of illness in all age groups, including ...agnostics Incorporated (NYSE: DGX ), the world,s...on and services. ,, In its most recent Quest D...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswir...y, Executive Director of the Nevada Health Care As...on (NHCA) commends and thanks Senate Majority Lead...ion a step closer toward our goal of protecting ev...ing home care, and preserving the strength and via...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...n in people with diabetes than in those without th...sue of Archives of Ophthalmology , one of the JA...ion Americans had diagnosed diabetes mellitus in 2...ls with diagnosed diabetes will increase to 48.3 m...
... ,can,t remember anything, study says , , ...k may do more than help guide your daily sleep/wak...ng and memory, say Stanford University researchers...ut it, they "can,t remember anything," said lead a...
... on October 30 - - Presentation at Oppenheimer,s ... November 4 -, - Annual Analyst Day...s on November 7 -, S...Probe will release its third quarter 2008 financia...
...nal study Study needed because of low cardia...Advanced Circulatory Systems,Inc. ( http://www.adv...,received an additional $1.5 million in funding fr...a hospital. Oshkosh is one,of six sites included i...
...t Rights Management System, Supports Global Pharm...d, WEST CHESTER, Pa., Oct. 13 Modevity, LLC anno...anufacturer has integrated,Modevity,s Imperium tec...eo content. Imperium is applied to this,new medica...
...RT WORTH, Texas, Oct. 13 The Dannon Company, Inc.... the Will Rogers Memorial,Center. The company, whi...,out thousands of bottles of free Dannon smoothies...s about their food choices,to ensure a healthy fut...
Other Medicine News:Health News:Vision loss more common in people with diabetes 2Health News:Circadian Rhythm Plays Role in Memory 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 3Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: